Seneca Therapeutics has a total of 31 patents globally. Of these 31 patents, more than 90% patents are active. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Seneca Therapeutics.
Seneca Therapeutics was founded in the year 2018. Seneca Therapeutics is a biotechnology company involved in development of novel cancer vaccines and oncolytic immunotherapeutics, known as Seneca Valley Virus (SVV) for treatment of cancer.
Do read about some of the most popular patents of Seneca Therapeutics which have been covered by us in this article and also you can find Seneca Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Seneca Therapeutics patent portfolio.
How many patents does Seneca Therapeutics have?
Seneca Therapeutics has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 28 patents are active.
How Many Patents did Seneca Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Seneca Therapeutics Applications Filed | Seneca Therapeutics Patents Granted |
| 2023 | 2 | – |
| 2022 | 13 | – |
| 2021 | 1 | – |
| 2020 | 15 | – |
How many Seneca Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Seneca Therapeutics File in Different Countries?
Countries in which Seneca Therapeutics Filed Patents
| Country | Patents |
| Europe (EPO) | 4 |
| South Africa | 4 |
| Australia | 4 |
| Brazil | 4 |
| Canada | 4 |
| Israel | 4 |
| Japan | 2 |
| United States Of America | 2 |
Where are Research Centers of Seneca Therapeutics Patents Located?
The Research Centers of Seneca Therapeutics is located in the United States of America.
List of Seneca Therapeutics Patents
| Seneca Therapeutics Patents | Title |
| US20220249584A1 | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| US20220202884A1 | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| EP4281549A1 | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| EP4274593A1 | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| EP3999087A4 | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| EP3952896A4 | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| IL304170A | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| IL304280A | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| BR112023014346A2 | Seneca Valley Armed Virus Oncolytic Therapy Compositions And Methods Thereof |
| BR112023013781A2 | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| ZA202306664A | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| ZA202306693A | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| AU2022210419A1 | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| AU2022205429A1 | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| CA3207261A1 | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| CA3207860A1 | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| BR112022000928A2 | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Of The Same |
| AU2020315800A1 | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| IL289912A | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| ZA202200829A | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| BR112021020369A2 | Compositions And Methods Of Use Of Seneca Valley Virus (Svv) For Treatment Of Cancer |
| AU2020272054A1 | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| IL287117A | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| ZA202107941A | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| CA3147640A1 | Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof |
| CA3136671A1 | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
| JP2022541234A5 | Second-Generation Seneca Valley Virus Oncolytic Therapy: Its Composition And Methods |
| JP2022527412A5 | Compositions And Methods Of Using Seneca Valley Virus (Svv) To Treat Cancer |
| WO2022159508A1 | Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof |
| WO2022150769A1 | Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor |
| WO2020210711A1 | Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer |
What are Seneca Therapeutics key innovation segments?
What Technologies are Covered by Seneca Therapeutics?
The chart below distributes patents filed by Seneca Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Seneca Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Seneca Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!